A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

Q: I just learned I have prediabetes. I also learned that a lot of people with pancreatic cancer have trouble with blood ...

Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is ...

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.

Discover why pancreatic cancer's warning signs often go unnoticed, masquerading as everyday health issues, learn the crucial red flags that shouldn't be ignored ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.

Coach Wallace was not only a mentor and a leader but also a true friend to the Southern University Human Jukebox. His support for us and his love for this university were undeniable. His infectious ...

Two students from Northern Ireland are preparing to run the equivalent of over six marathons in a week for charity in the ...